Tag Archive for: Investor
Insights from Optimum’s 15th Annual Healthcare Investor Conference 2023
Optimum Strategic Communications celebrated its 15th Annual Healthcare Investor Conference – marking its crystal anniversary – and what a sparkler it was! Optimism, preparation, and resilience, these were the key takeaways from our wonderful speakers on Wednesday 11 October at the Wellcome Trust. Check out our panel summaries below to learn more or to rediscover […]
Optimum’s 15th Annual Healthcare Investor Conference 2023 | Save the date
6TH OCTOBER 2022 | LONDON
Novo Holdings invests in proteomics technology company, Evosep
COPENHAGEN, DENMARK — Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the standardisation of proteomics for clinical use. The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s standardised liquid chromatography platform. The new […]
